Physicochemical characterization of the freezing behavior of mannitol-human serum albumin formulations

AAPS PharmSciTech

Volumn 7, Issue 4, 2006, Pages

  Hawe, Andrea ^a   Friess, Wolfgang ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

DSC; Freezing; HSA; LTXRD; Mannitol

Indexed keywords

HUMAN SERUM ALBUMIN; MANNITOL; N ACETYLTRYPTOPHAN; OCTANOIC ACID; SODIUM CHLORIDE; EXCIPIENT; SERUM ALBUMIN;

ARTICLE; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; FREEZE DRYING; FREEZING; GLASS TRANSITION TEMPERATURE; LOW TEMPERATURE; PHYSICAL CHEMISTRY; PROTEIN ANALYSIS; PROTEIN STABILITY; X RAY POWDER DIFFRACTION; CHEMISTRY; CONFORMATION; DRUG FORMULATION; DRUG STABILITY; HUMAN; MATERIALS TESTING; METHODOLOGY; TRANSITION TEMPERATURE;

CHEMISTRY, PHARMACEUTICAL; DRUG COMPOUNDING; DRUG STABILITY; EXCIPIENTS; FREEZE DRYING; HUMANS; MANNITOL; MATERIALS TESTING; MOLECULAR CONFORMATION; SERUM ALBUMIN; SODIUM CHLORIDE; TRANSITION TEMPERATURE;

EID: 33845801620     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/pt070494     Document Type: Article

References (40)

1. Liu J, Viverette T, Virgin M, Anderson M, Paresh D. A study of the impact of freezing on the lyophilization of a concentrated formulation with a high fill depth. Pharm Dev Technol. 2005;10:261-272.
2. Searles JA, Carpenter JF, Randolph TW. Annealing to optimize the primary drying rate, reduce freezing-induced drying rate heterogeneity, and determine Tg' in pharmaceutical lyophilization. J Pharm Sci. 2001;90:872-887.
3. Lu X, Pikal M. Freeze-drying of mannitol-trehalose-sodium chloride-based formulations: the impact of annealing on dry layer resistance to mass transfer and cake structure. Pharm Dev Technol. 2004;9:85-95.
4. Cannon A, Trappler E. The influence of lyophilization on the polymorphic behavior of mannitol. PDA J Pharm Sci Technol. 2000;54:13-22.
5. Telang C, Yu L, Suryanararyanan R. Effective inhibition of mannitol crystallization in frozen solutions by sodium chloride. Pharm Res. 2003;20:660-667.
6. Mazzobre MF, Longinotti MP, Corti HR, Buera MP. Effect of salts on the properties of aqueous sugar systems, in relation to biomaterial stabilization, I: water sorption behavior and ice crystallization/melting. Cryobiology. 2001;43:199-210.
7. Her LM, Deras M, Nail SL. Electrolyte-induced changes in glass transition temperatures of freeze-concentrated solutes. Pharm Res. 1995;12:768-772.
8. Akers MJ, Milton N, Byrn SR, Nail SL. Glycine crystallization during freezing: the effect of salt form, pH, and ionic strength. Pharm Res. 1995;12:1457-1461.
9. Shalaev EY, Franks F, Echlin P. Crystalline and amorphous phases in the ternary system water-sucrose-sodium chloride. J Phys Chem. 1996;100:1144-1152.
10. Nicolajsen H, Hvidt A. Phase behavior of the system trehalose-NaCl-water. Cryobiology. 1994;31:199-205.
11. Hanish WH, Fernandes PM, Taforo T, inventors. Cetus Corporation, assignee. Stable formulations for lipophilic IL-2 proteins. US patent 4 992 271. February 12, 1991.
12. Pikal MJ, Dellerman KM, Roy ML, Riggin RM. The effects of formulation variables on the stability of freeze-dried human growth hormone. Pharm Res. 1991;8:427-436.
13. Kim A, Akers M, Nail S. The physical state of mannitol after freeze-drying: effect of mannitol concentration, freezing rate and a non-crystallizing cosolute. J Pharm Sci. 1998;87:931-935.
14. Lueckel B, Bodmer D, Helk B, Leuenberger H. Formulations of sugars with amino acids or mannitol - influence of concentration ratio on properties of the freeze-concentrate and the lyophilizate. Pharm Dev Technol. 1998;3:325-336.
15. Liao X, Krishnamurthy R, Suryanarayanan R. Influence of the active pharmaceutical ingredient concentration on the physical state of mannitol - implications in freeze-drying. Pharm Res. 2005;22:1978-1985.
16. McGoff P, Scher DS. Solution formulation of Proteins/Peptides. In: McNally EJ, ed. Protein formulation and Delivery; Drugs and the Pharmaceutical Science. New York, NY: Marcel Dekker Inc; 1999: 139-158.
17. Dawson PJ. Effect of formulation and freeze-drying on the long-term stability of rDNA-derived cytokines. Dev Biol Stand. 1992;74:273-284.
18. Food and Drug Administration. Code of Federal Regulations: Albumin (Human). vol. 7. Rockville, MD: April 1, 2006:640.80. Title 21.
19. Scatchard G, Jr, Strong LE, Jr, Hughes WL, Jr, Ashworth JN, Sparrow AH. Chemical, clinical, and immunological studies and the products of human plasma fractionation, XXVI: the properties of human serum albumin at low salt content. J Clin Invest. 1945;24:671-679.
20. Ballou GA, Boyer PD, Luck JM, Lum GF. The heat coagulation of human albumin. J Biol Chem. 1944;153:589-605.
21. Arakawa T, Kita Y. Stabilizing effects of caprylate and acetyltryptophanate on heat-induced aggregation of bovine serum albumin. Biochim Biophys Acta. 2000;1479:32-36.
22. Saso L, Valentini G, Grippa E, Leone MG, Silvestrini B. Effect of selected substances on heat-induced aggregation of albumin, IgG, and lysozyme. Res Commun Chem Pathol Pharmacol. 1998;102:15-28.
23. Hawe A, Frieß W. Physico-chemical lyophilization behavior of mannitol, human serum albumin formulations. Eur J Pharm Sci. 2006; 28:224-232.
24. Yu L. Amorphous pharmaceutical solids: preparation, characterization and stabilization. Adv Drug Del Rev. 2001,48:27-42.
25. Cavatur R, Vemuri N, Pyne A, Chrzan Z, Toledo-Velasquez D, Suryanararyanan R. Crystallization behavior of mannitol in frozen aqueous solutions. Pharm Res. 2002;19:894-900.
26. Meredith P, Donald A, Payne R. Freeze-drying: in situ observations using cryoenvironmental scanning electron microscopy and differential scanning calorimetry. J Pharm Sci. 1996;85:631-637.
27. Gatlin L, Deluca PP. A study of the phase transitions in frozen antibiotic solutions by differential scanning calorimetry. J Parenter Drug Assoc. 1980;34:398-408.
28. Izutsu K, Kojima S. Excipient crystallinity and its protein-structure-stabilizing effect during freeze-drying. J Pharm Pharmacol. 2002; 54:1033-1039.
29. Shalaev EY, Franks F. Structural glass transition and thermophysical processes in amorphous carbohydrates and their supersaturated solutions. J Chem Soc, Faraday Trans. 1995;91:1511-1517.
30. Craig DQM, Royall PG, Kett VL, Hopton ML. The relevance of the amorphous state to pharmaceutical dosage forms: glassy drugs and freeze-dried systems. Int J Pharm. 1999;179:179-207.
31. Franks F. Solid aqueous solution. Pure Appl Chem. 1993;65: 2527-2537.
32. Pikal MJ. Freeze-drying of proteins, part I: process design. BioPharm. 1990;3:17-27.
33. Pikal MJ. Freeze-drying of proteins, part II: formulation selection. BioPharm. 1990;3:26-30.
34. Chen T, Oakley DM. Thermal analysis of proteins of pharmaceutical interest. Thermochim Acta. 1995;248:229-244.
35. Jennings TA. Lyophilization: Introduction and Basic Principles. Denver, CO: Interpharm Press; 1999.
36. Pikal MJ, Shah S. The collapse temperature in freeze drying: dependence on measurement methodology and rate of water removal from the glassy phase. Int J Pharm. 1990;62:165-186.
37. Knopp SA, Chongprasert S, Nail SL. The relationship between the TMDSC curve of frozen sucrose solutions and collapse during freeze-drying. J Therm Anal Calorim. 1998;54: 659-672.
38. Cavatur R, Suryanarayanan R. Characterization of frozen aqueous solutions by low temperature X-ray powder diffractometry. Pharm Res. 1998;15:194-199.
39. Yu L, Milton N, Groleau E, Mishra D, Vansickle R. Existence of a mannitol hydrate during freeze-drying and practical implications. J Pharm Sci. 1999;88:196-198.
40. Rodríguez-Hornedo N, Murphy D. Significance of controlling crystallization mechanisms and kinetics in pharmaceutical systems. J Pharm Sci. 1999;88:651-660.